Eleven Experts from Leading Medical Institutions and Eight Experts from Eisai Publish Full Results of Lecanemab Phase 3 Confirmatory Clarity Ad Study for Early Alzheimer’s Disease in the New England Journal of Medicine

TOKYO, Nov 30, 2022 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. and Biogen Inc. announced today that the results from Eisai’s large global Phase 3 confirmatory Clarity AD clinical study of lecanemab (development code: BAN2401), an investigational anti-amyloid beta (Abeta) protofibril antibody for the treatment of mild cognitive impairment (MCI) due to Alzheimer’s […]

Jiayin Group Inc. to Release Second Quarter 2022 Unaudited Results on Thursday, August 18, 2022

SHANGHAI, China, Aug. 11, 2022 (GLOBE NEWSWIRE via SEAPRWire.com) — Jiayin Group Inc. (“Jiayin” or the “Company”) (NASDAQ: JFIN), a leading fintech platform in China, today announced that it will release its financial results for the second quarter 2022 before the U.S market opens on Thursday, August 18, 2022. The Company will conduct a conference […]

Agora, Inc. to Report Second Quarter 2022 Financial Results on August 15, 2022

SANTA CLARA, Calif., Aug. 01, 2022 (GLOBE NEWSWIRE via SEAPRWire.com) — Agora, Inc. (NASDAQ: API) (“Agora”), a pioneer and leading platform for real-time engagement APIs, will release its financial results for the second quarter ended June 30, 2022 after the close of U.S. markets on August 15, 2022. Agora will host a conference call to […]

AB INTL GROUP Reports of Financial Results for the Nine Months Ended May 31, 2022

NEW YORK, July 18, 2022 (GLOBE NEWSWIRE via SEAPRWire.com) — AB International Group Corp. (OTCQB: ABQQ), an intellectual property (IP) and movie investment and licensing firm, announces its unaudited financial results for the nine months ended May 31, 2022. The financial results have been filed in a 10-Q with the U.S. Securities and Exchange Commission […]